Skip to main content
. Author manuscript; available in PMC: 2019 Aug 7.
Published in final edited form as: Toxicol Appl Pharmacol. 2018 Apr 23;349:21–28. doi: 10.1016/j.taap.2018.04.029

Fig. 5.

Fig. 5.

Cariprazine and AY9944 affect the residual cholesterol synthesis (RCS) of control human fibroblasts in a dose-dependent manner. At 5–10 nM of both compounds, the RCS values determined in control cells are comparable to those of values determined for several SLOS cell lines, see Reference 28.